FDA approves COVID-19 vaccine mix-and-match clinical trial

FILE PHOTO: A nurse fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination drive on September 29, 2021. REUTERS/Emily Elconin

MANILA, Philippines — The Food and Drug Administration (FDA) has approved the COVID-19 mix-and-match clinical trials, the Department of Science and Technology (DOST) announced Friday.

DOST Undersecretary Rowena Guevara said the FDA approved the clinical trials on November 16.

“Natapos na, finally, ang regulatory review ng mix-and-match. Ang application para sa clinical trial ay naaprubahan na ng FDA noong November 16,” Guevara said during the Laging Handa briefing.

(The regulatory review for the mix-and-match of COVID-19 vaccines has finally finished and the application for clinical trials has been approved by the FDA last November 16.)

“Ang trial ay nagsimula na ring mag-screen ng participants noong sumunod na araw sa kanilang trial site sa Marikina,” she added.

(The screening of participants for the trial also began the following day at their trial site in Marikina.)

The dry run for the mix-and-match clinical trials for COVID-19 vaccines started in October this year.

READ: https://newsinfo.inquirer.net/1506020/dost-starts-clinical-trials-for-mix-and-match-vaccines

Subscribe to our daily newsletter

For more news about the novel coronavirus click here.

What you need to know about Coronavirus.

For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next

Don’t miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

For feedback, complaints, or inquiries, contact us.

Source link


Please enter your comment!
Please enter your name here